1-2 of 2
Tengfei Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis

Open Access
Yuqin Song, Quanli Gao, Huilai Zhang, Lei Fan, Jianfeng Zhou, Dehui Zou, Wei Li, Haiyan Yang, Ting Liu, Quanshun Wang, Fangfang Lv, Haiyi Guo, Xia Zhao, Dan Wang, Pei Zhang, Yidi Wang, Lei Wang, Tengfei Liu, Yun Zhang, Zhirong Shen, Jane Huang, Jun Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1147–1156.
https://doi.org/10.1158/1078-0432.CCR-21-2023
Published: 15 March 2022
View articletitled, Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
Open the PDF for Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis in another window
Includes: Supplementary data
Journal Articles

An Imageable Metastatic Treatment Model of Nasopharyngeal Carcinoma

Free
Tengfei Liu, Yanqin Ding, Weibing Xie, Zuguo Li, Xiaoyan Bai, Xin Li, Weiyi Fang, Caiping Ren, Shuang Wang, Robert M. Hoffman, Kaitai Yao
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3960–3967.
https://doi.org/10.1158/1078-0432.CCR-07-0089
Published: 02 July 2007
View articletitled, An Imageable Metastatic Treatment Model of Nasopharyngeal Carcinoma
Open the PDF for An Imageable Metastatic Treatment Model of Nasopharyngeal Carcinoma in another window